153 related articles for article (PubMed ID: 23334957)
1. Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.
Kabbage M; Trimeche M; Bergaoui S; Hammann P; Kuhn L; Hamrita B; ben Nasr H; Chaieb A; Chouchane L; Chahed K
Tumour Biol; 2013 Apr; 34(2):1177-88. PubMed ID: 23334957
[TBL] [Abstract][Full Text] [Related]
2. Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.
Kabbage M; Trimeche M; Ben Nasr H; Hammann P; Kuhn L; Hamrita B; Chaieb A; Chouchane L; Chahed K
Tumour Biol; 2012 Dec; 33(6):2279-88. PubMed ID: 22972503
[TBL] [Abstract][Full Text] [Related]
3. Tropomyosin-4 correlates with higher SBR grades and tubular differentiation in infiltrating ductal breast carcinomas: an immunohistochemical and proteomics-based study.
Kabbage M; Trimeche M; Ben Nasr H; Hammann P; Kuhn L; Hamrita B; Chahed K
Tumour Biol; 2013 Dec; 34(6):3593-602. PubMed ID: 23812729
[TBL] [Abstract][Full Text] [Related]
4. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.
Somiari RI; Sullivan A; Russell S; Somiari S; Hu H; Jordan R; George A; Katenhusen R; Buchowiecka A; Arciero C; Brzeski H; Hooke J; Shriver C
Proteomics; 2003 Oct; 3(10):1863-73. PubMed ID: 14625848
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
Lwin ZM; Guo C; Salim A; Yip GW; Chew FT; Nan J; Thike AA; Tan PH; Bay BH
Mod Pathol; 2010 Dec; 23(12):1559-66. PubMed ID: 20834237
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
Abd El-Rehim D; Ali MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of calreticulin in malignant and benign breast tumors: relationship with humoral immunity.
Erić-Nikolić A; Milovanović Z; Sánchez D; Pekáriková A; Džodić R; Matić IZ; Tučková L; Jevrić M; Buta M; Rašković S; Juranić Z
Oncology; 2012; 82(1):48-55. PubMed ID: 22310016
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
10. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
12. Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses.
Chahed K; Kabbage M; Ehret-Sabatier L; Lemaitre-Guillier C; Remadi S; Hoebeke J; Chouchane L
Int J Oncol; 2005 Nov; 27(5):1425-31. PubMed ID: 16211239
[TBL] [Abstract][Full Text] [Related]
13. Enhanced humoral immunity in breast cancer patients with high serum concentration of anti-HER2 autoantibody.
Sato Y; Shimoda M; Sota Y; Miyake T; Tanei T; Kagara N; Naoi Y; Kim SJ; Noguchi S; Shimazu K
Cancer Med; 2021 Feb; 10(4):1418-1430. PubMed ID: 33506656
[TBL] [Abstract][Full Text] [Related]
14. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
15. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.
Xiao M; Jia S; Wang H; Wang J; Huang Y; Li Z
J Cancer Res Clin Oncol; 2013 Apr; 139(4):661-7. PubMed ID: 23292099
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 is a prognostic marker for hormone receptor positive tumors.
Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
[TBL] [Abstract][Full Text] [Related]
18. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
[TBL] [Abstract][Full Text] [Related]
19. A comparative proteomic study identified calreticulin and prohibitin up-regulated in adrenocortical carcinomas.
Yang MS; Wang HS; Wang BS; Li WH; Pang ZF; Zou BK; Zhang X; Shi XT; Mu DB; Zhang DX; Gao YS; Sun XW; Xia SJ
Diagn Pathol; 2013 Apr; 8():58. PubMed ID: 23587357
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
